Joanna Crawford

 

Joanna Crawford

Senior Research Assistant, Inflammasome Lab

 

 

Joanna joined the Inflammasome lab in April 2021 as a Senior Research assistant. Joanna has over 20 years of experience in biomedical research and has published over 70 papers. After completing her Master of Science (University of Victoria, Canada) she joined the IMB, working in labs focussed on exploring genomics in the clinical diagnostics space. Now as part of Kate Schroder’s Inflammasome Lab, her research aims to design new functional diagnostic assays for inflammasome-driven autoinflammatory disease (AD).

 

CONTACTS AND LINKS


 

Email: j.crawford2@uq.edu.au

Office Telephone: +61 7 3346 2356

 

Institute for Molecular Bioscience

Google Scholar

ORCiD

ResearcherID

 

AWARDS AND PUBLICATIONS


 

 

EDUCATION

 

2007 Master of Science, University of Victoria, Canada.

 

2002 Affiliate Lecturer, Department of Paediatrics, University of Adelaide.

 

1998 Graduate Diploma in Health Counselling, University of South Australia.

 

1993 Bachelor of Science Honours, University of Adelaide.

 

1991 Bachelor of Science, University of Adelaide.

 

 

 

 

Helman G, Lajoie BR, Crawford J, Takanohashi A, Walkiewicz M, Dolzhenko E, Gross AM, Gainullin VG, Bent SJ, Jenkinson EM, Ferdinandusse S, Waterham HR, Dorboz I, Bertini E, Miyake N, Wolf N, Abbink TEM, Kirwin SM, Tan CM, Hobson GM, Guo L, Ikegawa S, Pizzino A, Schmidt JL, Bernard G, Schiffmann R, van der Knaap MS, Simons C, Taft RJ Vanderver A (2020).
Genome sequencing in persistently unsolved white matter disorders. Annals of Clinical and Translational Neurology, 7 (1), 144-152. doi: 10.1002/acn3.50957.

 

Hudson R, Patel C, Hawley CM, O’Shea S, Snelling P, Ho G, Holman K, Bennetts B, Crawford J, Francis L, Simons C, Mallett A (2019).
Adult-Diagnosed Nonsyndromic Nephronophthisis in Australian Families Caused by Biallelic NPHP4 Variants. AJKD. 74(6).

 

Xu J, Falconer C, Nguyen Q, Crawford J, McKinnon BD, Mortlock S, Senabouth A, Andersen S, Hewitt AW, Chiu HS, Jiang L, Palpant N, Mueller MD, Pébay A, Yang J, Montgomery GW, Powell J, Coin L (2019).
Genotype-free demultiplexing of pooled single-cell RNA-seq. Genome Biol. 20: 290.

 

Yan H*, Helman G*, Ji H, Crawford J, Kubisiak T, Bent SJ, Jiangxi J, Taft RJ, Wu Y, Pop A, Li D, de Vries LS, Jiang Y, Salomons GS, van der Knaap MS, Simons C, Burmeiste M, Wang J, Wolf NL (2019).
De novo mutations in TMEM63A result in transient hypomyelination during infancy. Am J Hum Genet. 105(5):996-1004.

 

Kanca O, Andrews JC, Lee PT, Patel C, Braddock SR, Slavotinek AM, Cohen JS, Gubbels CS, Aldinger KA, Williams J, In daram M, Fatemi A, Yu TW, Agrawal PB, Vezina G, Simons C, Crawford J, Lau CC; Undiagnosed Diseases Network, Chung WK, Markello TC, Dobyns WB, Adams DR, Gahl WA, Wangler MF, Yamamoto S, Bellen HJ, Malicdan MCV (2019).
De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia. Am J Hum Genet. 105(3):672-674.

 

van der Knaap MS, Bugiani M, Mendes MI, Riley LG, Smith DEC, Rudinger-Thirion J, Frugier M, Breur M, Crawford J, van Gaalen J, Schouten M, Willems M, Waisfisz Q, Mau-Them FT, Roodenburg RJ, Taft RJ, Keren B, Christodoulou J, Depienne C, Simons C, Salomons GS, Mochel F (2019).
Bi-allelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy. Neurology. 92(11):e1225-e1237.

 

Helman G, Sharma S, Crawford J, Patra B, Jain P, Bent SJ, Saran RK, Taft RJ, van der Knaap MS, Simons C (2019).
Leukoencephalopathy due to mutations in GFPT1-associated congenital myasthenic syndrome: a phenotype expansion? Neurology. 92(6):e587-e593.

 

Deveson IW, Brunck ME, Blackburn J, Tseng E, Hon T, Clark T, Clark MB, Crawford J, Dinger ME, Nielson LK, Mattick JS, Mercer TR (2018).
Universal Alternative Splicing of Noncoding Exons. Cell Systems. 6(2):245-255.

 

Forbes TA, Howden SE, Lawlor K, Phipson B, Maksimovic J, Hale L, Wilson S, Quinlan C, Ho G, Holman K, Bennetts B, Crawford J, Trnka P, Oshlack A, Patel C, Mallett A, Simons C, Little MH (2018).
Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms. Am J Hum Genet. 102(5):816-831.

 

Choudary A, Vanichkina D, Ender C, Crawford J, Baillie G, Calcino A, Ru K, Taft RJ (2017).
Identification of miR-29b targets using 3-cyanovinylcarbazol containing mimics. RNA. 24(4):597-608.

 

Simons C, Dyment D, Bent SJ, Crawford J, D'Hooghe M, Kohlschütter A, Venkateswaran S, Helman G, Poll-The BT, Makowski CC, Ito Y, Kernohan K, Hartley T, Waisfisz Q, Taft RJ; Care4Rare Consortium, van der Knaap MS, Wolf NI (2017).
A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy. Brain. 140(12):3105-3111.

 

Bartonicek N, Clark MB, Quek XC, Torpy J, Pritchard A, Maag JL, Gloss BS, Crawford J, Taft RJ, Hayward NK, Montgomery GW, Mattick JS, Mercer TR, Dinger ME (2017).
Intergenic disease-associated regions are abundant in novel transcripts. Genome Biology. 18(241).

 

Miyake N, Wolf NI, Cayami FK, Crawford J, Bley A, Bulas D, Conant A, Bent SJ, Gripp KW, Hahn A, Humphray S, Kimura- Ohba S, Kingsbury Z, Lajoie BR, Lal D, Micha D, Pizzino A, Sinke RJ, Sival D, Stolte-Dijkstra I, Superti-Furga A, Ulrick N, Taft RJ, Ogata T, Ozono K, Matsumoto N, Neubauer BA, Simons C, Vanderver A (2017).
X-linked Hypomyelination with Spondylometaphyseal Dysplasia (H-SMD) associated with mutations in AIFM1. Neurogenetics. 18(4):185-194.

 

Betts JA, Moradi Marjaneh M, Al-Ejeh F, Lim YC, Shi W, Sivakumaran H, Tropée R, Patch AM, Clark MB, Bartonicek N, Wiegmans AP, Hillman KM, Kaufmann S, Bain AL, Gloss BS, Crawford J, Kazakoff S, Wani S, Wen SW, Day B, Möller A, Cloonan N, Pearson J, Brown MA, Mercer TR, Waddell N, Khanna KK, Dray E, Dinger ME, Edwards SL, French JD (2017).
Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage. Am J Hum Genet. 101(2):255-266.

 

Cayami F, Miyake N, Micha D, Crawford J, Conant A, Kingsbury Z, Bley A, Hahn A, Sival D, Kimura-Ohba S, Superti-Furga A, Gripp KW, Bulas D, Taft RJ, Ozono K, Matsumoto N, Neubauer BA, Simons C, Vanderver A, Wolf NI (2017).
Osteogenic transdifferentiation as ideal in vivo model for inherited hypomyelination with spondylometaphyseal dysplasia (H-SMD). Eur J Paediatr Neurol. 21:e20-e21.

 

Crawford J*, Bower NI*, Hogan BM, Taft RJ, Gabbett MT, McGaughran J, Simons C (2016).
Expanding the genotypic spectrum of CCBE1 mutations in Hennekam syndrome. Am J Med Genet. 170(10):2694-7.

 

Bell CC, Amaral PP, Kalsbeek A, Magor GW, Gillinder KR, Tangermann P, di Lisio L, Cheetham SW, Gruhl F, Frith J, Tallack MR, Ru KL, Crawford J, Mattick JS, Dinger ME, Perkins AC (2016).
The Evx1/Evx1as gene locus regulates anterior-posterior patterning during gastrulation. Sci Rep. 26(6):26657.

 

Bussotti G, Leonardi T, Clark MB, Mercer TR, Crawford J, Malquori L, Notredame C, Dinger ME, Mattick JS, Enright AJ (2016).
Improved definition of the mouse transcriptome via targeted RNA sequencing. Genome Res. 26(5):705-16.

 

Vanderver A, Simons C, Helman G, Crawford J, Wolf NI, Bernard G, Pizzino A, Schmidt JL, Takanohashi A, Miller D, Khouzam A, Rajan V, Ramos E, Chowdhury S, Hambuch T, Ru K, Baillie GJ, Grimmond SM, Caldovic L, Devaney J, Bloom M, Evans SH, Murphy JL, McNeill N, Fogel BL; Leukodystrophy Study Group, Schiffmann R, van der Knaap MS, Taft RJ (2016).
Whole exome sequencing in patients with white matter abnormalities. Ann Neurol. 79(6):1031-7.

 

Simons C, Griffin LB, Helman G, Golas G, Pizzino A, Bloom M, Murphy JL, Crawford J, Evans SH, Topper S, Whitehead MT, Schreiber JM, Chapman KA, Tifft C, Lu KB, Gamper H, Shigematsu M, Taft RJ, Antonellis A, Hou YM, Vanderver A (2015).
Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. Am J Hum Genet. 96(4):675-81.

 

Clark MB, Mercer TR, Bussotti G, Leonardi T, Haynes KR, Crawford J, Brunck ME, Cao KA, Thomas GP, Chen WY, Taft RJ, Nielsen LK, Enright AJ, Mattick JS, Dinger ME (2015).
Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing. Nat Methods. 12(4):339-42.

 

Mercer TR, Clark MB, Andersen SB, Brunck ME, Haerty W, Crawford J, Taft RJ, Nielsen LK, Dinger ME, Mattick JS (2015).
Genome-wide discovery of human splicing branchpoints. Genome Res. 25(2):290-303.

 

Simons C, Rash LD, Crawford J, Ma L, Cristofori-Armstrong B, Miller D, Ru K, Baillie GJ, Alanay Y, Jacquinet A, Debray FG, Verloes A, Shen J, Yesil G, Guler S, Yuksel A, Cleary JG, Grimmond SM, McGaughran J, King GF, Gabbett MT, Taft RJ (2015).
Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nat Genet. 47(1):73-7.

 

Corbett MA, Dudding-Byth T, Crock PA, Botta E, Christie LM, Nardo T, Caligiuri G, Hobson L, Boyle J, Mansour A, Friend KL, Crawford J, Jackson G, Vandeleur L, Hackett A, Tarpey P, Stratton MR, Turner G, Gécz J, Field M (2015).
A novel Xlinked trichothiodystrophy associated with a nonsense mutation in RNF113A. J Med Genet. 52(4):269-74.

 

Mercer TR*, Clark MB*, Crawford J*, Brunck ME, Gerhardt DJ, Taft RJ, Nielsen LK, Dinger ME and Mattick JS (2014).
Targeted sequencing for gene discovery and quantification using RNA CaptureSeq. Nat Protoc. 9(5):989-1009.

 

Simons C, Wolf NI, McNeil N, Caldovic L, Devaney JM, Takanohashi A, Crawford J, Ru K, Grimmond SM, Miller D, Tonduti D, Schmidt JL, Chudnow RS, van Coster R, Lagae L, Kisler J, Sperner J, van der Knaap MS, Schiffmann R, Taft RJ, Vanderver A (2013).
A De Novo Mutation in the beta-Tubulin Gene TUBB4A Results in the Leukoenceph-alopathy Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum. Am J Hum Genet. 92(5):767-73.

 

Taft RJ, Vanderver A, Leventer RJ, Damiani SA, Simons C, Grimmond SM, Miller D, Schmidt J, Lockhart PJ, Pope K, Ru K, Crawford J, Rosser T, de Coo IF,Juneja M, Verma IC, Prabhakar P, Blaser S, Raiman J, Pouwels PJ, Bevova MR, Abbink TE, van der Knaap MS, Wolf NI (2013).
Mutations in DARS Cause Hypomyelination with Brain Stem and Spinal Cord Involvement and Leg Spasticity. Am J Hum Genet. 92(5):774-80.

 

Tonkin ML, Crawford J, Lebrun ML, Boulanger MJ (2013).
Babesia divergens and Neospora caninum apical membrane antigen 1 structures reveal selectivity and plasticityin api-complexan parasite host cell invasion. Protein Sci. 22(1):114- 27.

 

Smart CE, Askarian Amiri ME, Wronski A, Dinger ME, Crawford J, Ovchinnikov DA, Vargas AC, Reid L, Simpson PT, Song S, Wiesner C, French JD, Dave RK, da Silva L, Purdon A, Andrew M, Mattick JS, Lakhani SR, Brown MA, Kellie S (2012).
Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. PLoS One. 7(7):e40742.

 

Cossetti C, Mercer TR, Alpi E, Leonardi T, Drago D, Iraci N, Alfaro-Cervello C, Dinger ME, Dietmann S, Crawford J, Caddeo C, Verdugo MG, Bachi A, Mattick JS, Pluchino S (2012).
Neural stem cells sort protein and RNA cargoes for export with exosomes in response to inflammation. J Neuroimmunology. 253(1-2):127-127.

 

Mercer TR, Gerhardt DJ, Dinger ME, Crawford J, Trapnell C, Jeddeloh JA, Mattick JS and Rinn JL (2011).
Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol. 13;30(1):99-104.

 

Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood A-MJ, Haugen E, Bracken CP, Rackham O, Stamatoyannopoulos JA, Filopovska A, and Mattick JS (2011).
The human mitochondrial transcriptome. Cell. 146(4):645- 658.

 

Tonkin ML, Roques M, Lamarque MH, Pugnière M, Douguet D, Crawford J, Lebrun M and Boulanger MJ (2011).
Host cell invasion by Apicomplexan parasites: Insights from the structure of AMA1 in complex with a RON2 peptide. Science. 333(6041):463-467.

 

Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS and Perera RJ (2011).
The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 71(11):3852-62.

 

Askarian-Amiri ME, Crawford J, French JD, Smith MA, Smart CE, Ru K, Mercer TR, Thompson EW, Lakhani SR, Vargas AC, Campbell IG, Brown MA, Dinger ME, Mattick JS (2011).
SNORD-host RNA Znfx1-as is a regulator of mammary development and a potential marker for breast cancer. RNA. 17(5):878-91.

 

Boulanger MJ, Tonkin ML, Crawford J (2010).
Apicomplexan parasite adhesins: novel strategies for targeting host cell carbohydrates. Curr Opin Struct Biol. 20(5):551-9.

 

Tonkin ML, Grujic O, Pearce M, Crawford J and Boulanger MJ (2010).
Structure of the micronemal protein 2 A/I domain from Toxoplasma gondii. Protein Sci.19(10):1985-90.

 

Crawford J, Tonkin ML, Grujic O and Boulanger MJ (2010).
Structural Characterization of Apical Membrane Antigen 1 (AMA1) from Toxoplasma Gondii. J Biol Chem. 285(20):15644-52.

 

Crawford J, Lamb E, Wasmuth J, Grujic O, Grigg ME and Boulanger MJ (2010).
Structural and Functional Characterization of SporoSAG: A SAG2 Related Surface Antigen from Toxoplasma Gondii. J Biol Chem. 285(16):12063-70.

 

Crawford J, Grujic O, Bruic E, Czjek M, Grigg ME, Boulanger MJ (2009).
Structural characterization of the bradyzoite surface antigen (BSR4) from Toxoplasma gondii: A unique addition to the SAG1 related superfamily. J Biol Chem. 284(14):9192-8.

 

Crawford J, Partington M, Corbett M, Lower K, Gécz J (2009).
Börjeson-Forssman-Lehmann Syndrome. Genetics of Obesity Syndromes. Oxford University Press.187-200.

 

Crawford J, Lower KM, Hennekam RCM, Van Esch H, Mégarbané A, Lynch SA, Turner G and Gécz J (2005).
Mutation screening in Börjeson-Forssman-Lehmann Syndrome (BFLS): identification of a novel PHF6 mutation in a female patient. J Med Genet. 43(3):238-43.

 

Kumar R, Neilsen PM, Crawford J, McKirdy R, Lee J, Powell JA, Saif Z, Martin JM, Lombaerts M, Cornelisse CJ, Cleton- Jansen AM and Callen DF (2005).
FBXO31 is the chromosome16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex. Cancer Res. 65(24):11304-13.

 

Lower KM, Solders G, Bondeson ML, Nelson J, Brun A, Crawford J, Malm G, Borjeson M, Turner G, Partington M, Gecz J (2004).
1024C>T (R342X) is a recurrent PHF6 mutation also found in the original Borjeson-Forssman-Lehmann syndrome family. Eur J Hum Genet. 12(10):787-9.

 

Bhalla K, Phillips HA, Crawford J, McKenzie OL, Mulley JC, Eyre H, Gardner AE, Kremmidiotis G, Callen DF (2004).
The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene. J Hum Genet. 49 :308-11.

 

Powell JA, Gardener AE, Bais AJ, Hinze SJ, Baker E, Whitmore S, Crawford J, Kochetkova M, Spendlove HE, Doggett NA, Sutherland GR, Callen DF and Kremmidiotis G (2002).
Sequencing, Transcript Identification and Quantitative Gene Expression Profiling in the Breast Cancer Loss of heterozygosity region 16q24.3 reveal three potential tumorsuppressor genes. Genomics. Sep;80(3):303-10.

 

Kochetkova M, McKenzie OLD, Bais AJ, Martin JM, Secker GA, Seshadri R, Powell JA, Hinze SJ, Gardener AE, Spendlove HE, O’Callaghan NJ, Cleton-Jansen A-M, Cornelisse CJ, Whitmore SA, Crawford J, Kremmidiotis G, Sutherland GR and Callen DF (2002).
CBFA2T3 (MTG16) is a Putative Breast Tumour Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 16q24.3. Cancer Res. 62 : 4599-4604.

 

Callen DF, Crawford J, Derwas C, Cleton-Jansen A-M, Cornelisse CJ, Baker E (2002).
Defining Regions of Loss of Heterozygosity of 16q in Breast Cancer Cell Lines. Cancer Genet Cytogenet 133 : 76-82.

 

Crawford J, Zielinski MA, Fisher LJ, Sutherland GR and Goldney RD (2002).
Is There a Relationship Between Wolfram Syndrome Carrier Status and Suicide? Am J Med Genet. (Neuropsychiatric Genetics) 114 : 343-346.

 

McRae JL, Murphy BF, Eyre HJ, Sutherland GR, Crawford J and Peter J. Cowan PJ (2002).
Location and structure of the human FHR-5 gene. Genetica. 114 : 157-161.

 

Cleton-Jansen A-M, Callen DF, Seshadri R, Goldup S, McCallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VTBHM, Harris WH, Millis R, Morgan NV, Barnes D, Matthew CG and Cornelisse CJ (2001).
Loss of Heterozygosity Mapping at Chromosome Arm 16q in 712 Breast Tumors Reveals Factors that Influence Delineation of Candidate Regions. Cancer Research 61 : 1171-1177. 9

 

Hulett MD, Pagler E, Hornby JR, Hogarth PM, Eyre HJ,. Baker EE, Crawford J, Sutherland GR, Ohms SJ, Parish CR (2001).
Isolation, Tissue Distribution, and Chromosomal Localization of a Novel Testis-Specific Human Four-Transmembrane Gene Related to CD20 and FcepsilonRI-beta. Biochem Biophys Res Commun. 280 : 374-9.

 

Parker RMC, Liu M, Eyre HJ, Copeland NG, Gilbert DJ, Crawford J, Sutherland GR, Jenkins NA and Herzog H (2000).
Yreceptor- like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse. Biochim Biophys Acta. 1491(1-3) : 369-75.

 

Parker RMC, Copeland NG, Eyre HJ, Liu M, Gilbert DJ, Crawford J, Couzens M, Sutherland GR, Jenkins NA and Herzog H (2000).
Molecular cloning and characterisation of GPR74 a novel G-protein coupled receptor closest related to the Yreceptor family. Molecular Brain Research 77: 199-208.

 

Crawford J, Sutherland GR and Goldney RD (2000).
No Evidence for Association of 5-HTA Receptor Polymorphism with Suicide. Am J Med Genet. (Neuropsychiatric Genetics) 96 : 879-880.

 

Cleton-Jansen A-M, Moerland EW, Pronk JC, van Berkel CGM, Apostolou S, Crawford J, Savoia A, Auerbach AD, Matthew CG, Callen DF and Cornelisse CJ (1999).
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3. Br J Cancer 79 : 1049-1052.

 

Liu M, Parker RMC, Darby K, Eyre HJ, Copeland NG, Crawford J, Gilbert DJ, Sutherland GR, Jenkins NA and Herzog H (1999).
GPR56, a Novel Secretin-like Human G-Protein-Coupled Receptor Gene. Genomics 55 : 296-305.

 

Crawford J, Ianzano L, Savino M, Whitmore S, Cleton-Jansen A-M, Settasatian C, d’Apolito M, Seshadri R, Pronk JC, Auerbach AD, Verlander PC, Matthew CG, Tipping AJ, Doggett NA, Zelante L, Callen DF and Savoia A (1999).
The PISSLRE Gene : Structure, Exon Skipping, and Exclusion as a Tumor Suppressor Gene in Breast Cancer. Genomics 56 : 90-97.

 

Crawford J, Hort YJ, Shine J and Iismaa TP (1999).
Human GALR1 galanin receptor (GALNR1) Map position 18q23. Chrom Res 7 : 243.

 

Baker E, Crawford J, Sutherland GR, Freeman C, Parish CR, Hulett MD (1999).
Human HPA endoglycosidase heparase Map position 4q21.3. Chrom Res 7 : 319.

 

Settasatian C, Whitmore SA, Crawford J, Bilton RL, Cleton-Jansen AM, Sutherland GR, Callen DF (1999).
Genomic structure and expression analysis of the spastic paraplegia gene, SPG7. Hum Genet. 105(1-2) : 139-44.

 

Savino M, d’Apolito M, Centra M, van Beerendonk HM, Cleton-Jansen A-M, Whitmore SA, Crawford J, Callen DF, Zelante L and Savoia A (1999).
Characterization of Copine VII, a New Member of the Copine Family, and It’s Exclusion as a Candidate in Sporadic Breast Cancers with Loss of Heterozygosity at 16q24.3. Genomics 61 : 219-226.

 

Hiki K, D’Andrea RJ, Furze J, Crawford J, Woollatt E, Sutherland GR, Vadas MA and Gamble JR (1999).
Cloning, Characterization , and Chromosomal Location of a Novel Human K+-Cl- Cotransporter. J Biol Chem 274 (15) : 10661- 10667.

 

Keough R, Woollatt E, Crawford J, Sutherland GR, Plummer S, Casey G and Gonda TJ (1999).
Molecular Cloning and Chromosomal Mapping of the Human Homologue of the MYB Binding Protein (P160) 1A (MYBBP1A) to 17p13.3. Genomics 62 : 483-489.

 

Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J and Callen DF (1998).
Localisation of Human Cadherin Genes to Chromosome Regions Exhibiting Cancer-Related Loss of Heterozygosity. Genomics 49 : 476-471.

 

Whitmore SA, Crawford J, Apostolou S, Eyre H, Baker E, Lower KM, Settasatian C, Goldup S, Seshadri R, Gibson RA, Matthew CG, Cleton-Jansen A-M, Savoia A, Pronk JC, Auerbach AD, Doggett NA, Sutherland GR and Callen DF (1998).
Construction of a High-Resolution Physical and Transcription Map of Chromosome 16q24.3 : A Region of Frequent Loss of Heterozygosity in Sporadic Breast Cancer. Genomics 50 : 1-8.

 

Cavanaugh JA, Callen DF, Wilson SR, Stanford PM, Sraml ME, Gorska M, Crawford J, Whitmore SA, Shlegel C, Foote S, Kohonen-Cornish M and Pavli P (1998).
Analysis of Australian Crohn’s disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann. Hum. Genet. 62 : 291-298.

 

Whitmore SA, C Settasatian C, Crawford J, Lower KM, Cornelisse CJ, Moerland EW, Cleton-Jansen A-M, Tipping AJ, Matthew CG, Savino M, Savoia A, Auerbach AD, VanBerkel C, Pronk JC, Doggett NA and Callen DF (1998).
Characterization 10 and screening for mutations in breast cancer of the growth arrest specific 11 (GAS11) and C16orf 3 genes at 16q24.3. Genomics 52 : 325-331.

 

Jenkins NA, Woollatt E, Crawford J, Gilbert DJ, Baldwin ME, Sutherland GR, Copeland NG and Achen MG (1997).
Mapping of the gene for vascular endothelial growth facor- D in mouse and man to the X chromosome. Chrom Res. 5 : 502-505.

 

Richards RI, Crawford J, Narahara K, Mangelsdorf M, Friend K, Staples A, Denton M, Easteal S, Hori T-A, Kondo I, Jenkins T, Goldman A, Panich V, Ferakova E and Sutherland GR (1996).
Dynamic mutation loci : allele distributions in different populations. Ann Hum. Genet. 60 : 391-400.

 

The Fanconi anaemia/Breast cancer consortium (1996).
Positional cloning of the Fanconi anaemia group A gene. Nat Genet. 14 : 324-328.

 

Crawford J, Labrinidis A, Carey WF, Nelson PV, Harvey JS and Morris CP (1995).
A Splicing Mutation (1898+1G(T) in the CFTR Gene Causing Cystic Fibrosis. Hum Mut. 5 : 101-102.